Structural and functional insights into the G protein-coupled receptors: CB1 and CB2
- PMID: 37646476
- PMCID: PMC10586759
- DOI: 10.1042/BST20221316
Structural and functional insights into the G protein-coupled receptors: CB1 and CB2
Abstract
The cannabinoid receptors CB1 and CB2 mediate a variety of physiological processes and continue to be explored as desirable drug targets. Both receptors are activated by the endogenous endocannabinoids and the psychoactive components of marijuana. Over the years, many efforts have been made to make selective ligands; however, the high degree of homology between cannabinoid receptor subtypes introduces challenges in studying either receptor in isolation. Recent advancements in structure biology have resulted in a surge of high-resolution structures, enriching our knowledge and understanding of receptor structure and function. In this review, of recent cannabinoid receptor structures, key features of the inactive and active state CB1 and CB2 are presented. These structures will provide additional insight into the modulation and signaling mechanism of cannabinoid receptors CB1 and CB2 and aid in the development of future therapeutics.
Keywords: G-protein-coupled receptors; cannabinoids; cryo-electron microscopy; crystallography.
© 2023 The Author(s).
Conflict of interest statement
The authors declare that there are no competing interests associated with the manuscript.
Figures


Similar articles
-
Crystal Structure of the Human Cannabinoid Receptor CB2.Cell. 2019 Jan 24;176(3):459-467.e13. doi: 10.1016/j.cell.2018.12.011. Epub 2019 Jan 10. Cell. 2019. PMID: 30639103 Free PMC article.
-
The pharmacology of cannabinoid receptors and their ligands: an overview.Int J Obes (Lond). 2006 Apr;30 Suppl 1:S13-8. doi: 10.1038/sj.ijo.0803272. Int J Obes (Lond). 2006. PMID: 16570099 Review.
-
Pharmacological actions of cannabinoids.Handb Exp Pharmacol. 2005;(168):1-51. doi: 10.1007/3-540-26573-2_1. Handb Exp Pharmacol. 2005. PMID: 16596770 Review.
-
Molecular basis for ligand modulation of the cannabinoid CB1 receptor.Br J Pharmacol. 2022 Jul;179(14):3487-3495. doi: 10.1111/bph.15627. Epub 2021 Aug 12. Br J Pharmacol. 2022. PMID: 34265078 Review.
-
Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.J Neuroimmune Pharmacol. 2010 Mar;5(1):103-21. doi: 10.1007/s11481-009-9177-z. Epub 2009 Oct 22. J Neuroimmune Pharmacol. 2010. PMID: 19847654 Review.
Cited by
-
Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases.Int J Mol Sci. 2024 Nov 27;25(23):12738. doi: 10.3390/ijms252312738. Int J Mol Sci. 2024. PMID: 39684447 Free PMC article. Review.
-
Exploring G Protein-Coupled Receptors in Hematological Cancers.ACS Pharmacol Transl Sci. 2024 Nov 21;7(12):4000-4009. doi: 10.1021/acsptsci.4c00473. eCollection 2024 Dec 13. ACS Pharmacol Transl Sci. 2024. PMID: 39698279
-
Utilization of Cannabidiol in Post-Organ-Transplant Care.Int J Mol Sci. 2025 Jan 15;26(2):699. doi: 10.3390/ijms26020699. Int J Mol Sci. 2025. PMID: 39859413 Free PMC article. Review.
-
Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer.J Cannabis Res. 2024 May 16;6(1):24. doi: 10.1186/s42238-024-00233-z. J Cannabis Res. 2024. PMID: 38755733 Free PMC article. Review.
References
-
- Howlett, A.C. (1985) Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. Mol. Pharmacol. 27, 429–436 - PubMed
-
- Devane, W.A., Dysarz, III, F.A., Johnson, M.R., Melvin, L.S. and Howlett, A.C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605–613 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources